Polygonum Multiflorum

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: hair longevity detox

Research Overview

Research on Polygonum multiflorum (Heshouwu) has focused most heavily on (i) phytochemistry and constituent identification (with >100 reported compounds, prominently stilbenes such as 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside/TSG and anthraquinones such as emodin and rhein), (ii) preclinical pharmacology spanning anti-inflammatory, antioxidant, neuroprotective, lipid-lowering, and anticancer-related activities, and (iii) toxicology—particularly herb-induced liver injury. Mechanistic studies frequently center on inflammation and immune modulation pathways, with recent work in Alzheimer’s disease models indicating TSG can reduce neuroinflammation and improve cognition in transgenic mice, plausibly via suppression of cGAS–STING signaling and downstream NLRP3 inflammasome activation. In parallel, emodin and rhein—also found in other medicinal plants—are widely reviewed for broad bioactivities (e.g., anticancer, anti-inflammatory, antimicrobial), and P. multiflorum is sometimes included in antiviral candidate lists (including for coronaviruses), though these claims are largely based on screening and preclinical inference rather than clinical demonstration.

The strongest evidence base, taken as a whole, supports two conclusions: first, that P. multiflorum contains multiple bioactive chemical classes with reproducible effects in cellular and animal models relevant to inflammation, neurodegeneration, metabolic disease, and cancer-related pathways; and second, that clinically significant hepatotoxicity is a well-documented safety concern for P. multiflorum products, with the broader hepatotoxicity literature on traditional Chinese medicines identifying P. multiflorum among individual herbs repeatedly implicated in liver injury. Pharmacokinetic observations further support biological plausibility by showing distribution of key constituents (e.g., TSG and emodin) across organs and tissues, but this does not by itself establish therapeutic efficacy in humans.

Key gaps requiring more research include: rigorous, well-controlled human clinical trials for specific indications (e.g., cognitive outcomes, hyperlipidaemia, inflammatory conditions) using standardized preparations; clearer dose–exposure–response relationships and comparative safety of raw versus processed products; and mechanistic toxicology to identify which constituents, metabolites, or combinations drive hepatotoxicity (anthraquinones are frequently implicated, but causality and interaction effects remain incompletely resolved). Additional priorities are improved quality control and adulterant surveillance, evaluation of herb–drug interactions, and stronger translational validation of antiviral and anticancer claims beyond in vitro or computational screening. Overall, the field is characterized by substantial preclinical promise alongside a comparatively stronger and clinically salient signal for liver toxicity, underscoring the need for standardized products and definitive human evidence.

1. What conditions has Polygonum Multiflorum been studied for?

  • Viral infections (including coronaviruses): Listed among medicinal plants with “promising inhibitory effect against coronavirus” in a broad natural-products antiviral review (no specific clinical context provided in the abstract).

  • Neurodegenerative disease / cognitive impairment (Alzheimer’s disease models): Tetrahydroxy stilbene glucoside (TSG), a constituent from Polygonum multiflorum, was studied in AD transgenic mice and in microglial cell culture models of neuroinflammation.

  • Hyperlipidaemia (high lipids): A comprehensive review reports anti-hyperlipidaemia effects and mentions use in pre-clinical and clinical practice (details not provided in the abstract).

  • Inflammation / immunomodulation: Reviews describe anti-inflammatory and immunomodulatory effects; mechanistic work in AD models links TSG to suppression of inflammatory signaling.

  • Cancer: Reviews describe anticancer activity for P. multiflorum extracts/compounds; emodin (found in P. multiflorum) is reviewed for anticancer properties.

  • Other conditions mentioned in reviews (preclinical/clinical use claimed): Parkinson’s disease, “anti-aging,” neuroprotection, and other diseases (not specified in detail in the abstracts).

  • Safety/toxicology focus: Herb-induced liver injury (HILI) and hepatotoxicity are repeatedly discussed, including increasing reports of P. multiflorum-associated liver injury.

2. Does it work in treating those conditions? Summarize the evidence.

  • Alzheimer’s disease / neuroinflammation (preclinical evidence): In an AD transgenic mouse study, treatment with TSG “distinctly improved” learning-memory ability and reduced inflammatory cytokines and microglial activation. Mechanistically, effects were linked to suppression of the cGAS–STING immune response and NLRP3 inflammasome activation. In BV2 microglial cells stimulated with LPS + IFN-γ, TSG reduced pro-inflammatory cytokines (e.g., IL‑1β, IL‑6, TNF‑α, IFN‑α/β) and interferon-regulated proteins (e.g., IFIT1, IRF7), and shifted microglia away from an M1-like activated state.

    Limitations: This is animal and cell-culture evidence; the abstract does not provide human clinical trial outcomes for AD.

  • Antiviral activity (suggestive, not definitive): P. multiflorum is included in a list of plants with “promising inhibitory effect against coronavirus,” and emodin is listed among molecules that “could be potential drug candidates against COVID-19.”

    Limitations: The abstract is a broad survey and does not provide specific experimental results, doses, viral targets, or clinical efficacy for P. multiflorum preparations.

  • Hyperlipidaemia, anti-aging, anti-inflammatory, anticancer (mixed preclinical/claimed clinical use): A systematic review states crude extracts and pure compounds are used as “effective agents in pre-clinical and clinical practice” for anti-aging, anti-hyperlipidaemia, anti-cancer and anti-inflammatory effects, among others.

    Limitations: The abstract does not specify trial designs, effect sizes, or quality of evidence; therefore efficacy in humans cannot be confirmed from these abstracts alone.

  • Emodin and rhein as constituents (evidence largely from broader pharmacology reviews): Emodin is reviewed as having multiple pharmacological activities (including “antivirs,” anti-inflammatory, antioxidant, anticancer), and rhein is reviewed for anti-inflammatory, antioxidant, anticancer, antimicrobial, and organ-protective activities.

    Limitations: These are compound-focused reviews; they do not establish that whole-herb P. multiflorum products are effective or safe for specific diseases in humans.

3. What health benefits does it have?

  • Anti-inflammatory / immunomodulatory effects: Reviews describe anti-inflammatory and immunomodulatory activity. In mechanistic AD-model work, TSG suppressed multiple inflammatory cytokines and microglial activation via cGAS–STING and NLRP3-related pathways.

  • Neuroprotective potential: The AD transgenic mouse study reported improved learning-memory performance with TSG alongside reduced neuroinflammation, supporting a neuroprotective hypothesis (preclinical).

  • Metabolic/cardiometabolic relevance: Anti-hyperlipidaemia is repeatedly mentioned in reviews (details not provided in the abstracts).

  • Anticancer potential: Reviews cite anticancer effects for P. multiflorum extracts/compounds; emodin and rhein are both reviewed as having anticancer activity (largely preclinical/experimental context in these abstracts).

  • Antiviral “candidate” activity: Included among plants/compounds proposed as potential antiviral candidates against coronaviruses (evidence level not detailed in the abstract).

  • Traditional-use claims (ethnomedical): Hair blackening, “liver and kidney-tonifying,” and anti-aging are described as traditional values; these are not the same as proven clinical benefits.

4. Does it have any downsides or side effects?

  • Hepatotoxicity (liver injury): Multiple abstracts emphasize liver toxicity risk.

    • A systematic review of P. multiflorum reports adverse effects including hepatotoxicity (and also nephrotoxicity and embryonic toxicity).

    • A hepatotoxicity-focused TCM review (since 2011) highlights “Polygonum multiflorum products” among herbs with potential health hazards and stresses the need for stringent risk/benefit evaluation.

    • A systematic review of DILI/HILI cohorts found 25% of liver injury cases were herb-related, and lists Polygonum multiflorum among the main herbs causing HILI. HILI was more common in females and more often hepatocellular in pattern (hepatocellular 78.8%).

    • A more recent PM-specific review notes PM-induced liver injury has been increasingly reported internationally since the first report in Hong Kong in 1996, and describes it as related to idiosyncratic hepatotoxicity (unpredictable susceptibility in some individuals).

  • Nephrotoxicity and embryonic toxicity: The systematic review explicitly states P. multiflorum extracts “can also lead to hepatotoxicity, nephrotoxicity and embryonic toxicity.”

  • Unclear toxic constituents and mechanisms: Reviews state the “responsible hepatotoxic compounds and mechanisms…are still not clear,” with controversy over whether anthraquinones (e.g., emodin) or stilbenes (e.g., TSG) are more critical. Proposed mechanisms include effects on oxidative phosphorylation, TCA cycle, bile acid excretion pathways, metabolic pathways, and genetic polymorphisms.

  • Processing matters: One review notes processing significantly affects chemical composition, pharmacological activities, and toxicity—implying product-to-product variability in both benefit and risk.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The abstracts do not identify specific genes, alleles, or validated pharmacogenomic markers that predict benefit or harm from Polygonum multiflorum or its key constituents.

  • What is suggested (but not specified): A PM-focused review lists “genetic polymorphisms” among mechanisms implicated in PM-induced hepatotoxicity, consistent with the idea that susceptibility may vary by genotype.

  • What is missing: No specific polymorphisms (e.g., HLA types, drug-metabolizing enzymes, transporters) are named in these abstracts, and no actionable genetic guidance can be derived from them.

  • Practical implication based on the abstracts: Because hepatotoxicity is described as idiosyncratic and potentially influenced by genetic factors, pharmacogenomic risk stratification is a plausible research direction, but it is not yet evidence-based from the provided text.

References

  1. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.
    Bikash Adhikari, Bishnu P Marasini, Binod Rayamajhee, Bibek Raj Bhattarai, Ganesh Lamichhane, Karan Khadayat, Achyut Adhikari, Santosh Khanal, Niranjan Parajuli (2021) - Phytotherapy research : PTR
  2. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review.
    Longfei Lin, Boran Ni, Hongmei Lin, Miao Zhang, Xuechun Li, Xingbin Yin, Changhai Qu, Jian Ni (2015) - Journal of ethnopharmacology
  3. Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties.
    Sahu Henamayee, Kishore Banik, Bethsebie Lalduhsaki Sailo, Bano Shabnam, Choudhary Harsha, Satti Srilakshmi, Naidu Vgm, Seung Ho Baek, Kwang Seok Ahn, Ajaikumar B Kunnumakkara (2020) - Molecules (Basel, Switzerland)
  4. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin.
    Ya Cui, Liu-Jing Chen, Tu Huang, Jian-Qiong Ying, Juan Li (2020) - Chinese journal of natural medicines
  5. Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STING.
    Dan Gao, Jin-Ping Hao, Bo-Ya Li, Ceng-Ceng Zheng, Bei-Bei Miao, Li Zhang, Ya-Li Li, Lin Li, Xing-Jie Li, Lan Zhang (2023) - European journal of pharmacology
  6. Rhein: A Review of Pharmacological Activities.
    Yan-Xi Zhou, Wei Xia, Wei Yue, Cheng Peng, Khalid Rahman, Hong Zhang (2015) - Evidence-based complementary and alternative medicine : eCAM
  7. Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations.
    R Teschke, A Wolff, C Frenzel, J Schulze (2014) - Alimentary pharmacology & therapeutics
  8. Polygonum multiflorum: Recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms.
    Tekleab Teka, Liming Wang, Jian Gao, Jiajia Mou, Guixiang Pan, Haiyang Yu, Xiumei Gao, Lifeng Han (2021) - Journal of ethnopharmacology
  9. Systematic review of published data on herb induced liver injury.
    Jung-Hwan Byeon, Ji-Hye Kil, Yo-Chan Ahn, Chang-Gue Son (2019) - Journal of ethnopharmacology
  10. A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient.
    Hao Sun, Guangwen Luo, Dahui Chen, Zheng Xiang (2016) - Frontiers in pharmacology
  11. Root Cultures, a Boon for the Production of Valuable Compounds: A Comparative Review.
    Masooma Jawad Hussain, Yawar Abbas, Naushaba Nazli, Sara Fatima, Samantha Drouet, Christophe Hano, Bilal Haider Abbasi (2022) - Plants (Basel, Switzerland)
  12. Phytochemistry, pharmacology, toxicology and detoxification of
    Jiawen Qian, Chenhang Feng, Ziyang Wu, Yuanmei Yang, Xiangfu Gao, Lingyan Zhu, Yang Liu, Yuancheng Gao (2024) - Frontiers in pharmacology
  13. Hepatoprotection and hepatotoxicity of Heshouwu, a Chinese medicinal herb: Context of the paradoxical effect.
    Hongliang Li, Xuanbin Wang, Ying Liu, Dongfeng Pan, Ye Wang, Nian Yang, Longchao Xiang, Xiaojun Cai, Yibin Feng (2017) - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  14. Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds.
    Guy-Armel Bounda, Y U Feng (2015) - Pharmacognosy research
  15. Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb.
    Hai-Yan Jiang, Hui-Yu Gao, Jie Li, Tian-Yu Zhou, Shu-Ting Wang, Jian-Bo Yang, Rui-Rui Hao, Fei Pang, Feng Wei, Zhi-Gang Liu, Lian Kuang, Shuang-Cheng Ma, Jiu-Ming He, Hong-Tao Jin (2022) - Journal of ethnopharmacology
  16. Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein.
    Gang-Min Li, Jun-Ren Chen, Hui-Qiong Zhang, Xiao-Yu Cao, Chen Sun, Fu Peng, Yan-Peng Yin, Ziwei Lin, Lei Yu, Yan Chen, Yun-Li Tang, Xiao-Fang Xie, Cheng Peng (2021) - Evidence-based complementary and alternative medicine : eCAM
  17. Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells.
    Jae Young Shin, Yun-Ho Choi, Jaeyoon Kim, Se Young Park, You Jin Nam, So Young Lee, Jeong Hoon Jeon, Mu Hyun Jin, Sanghwa Lee (2020) - BMC complementary medicine and therapies
  18. Structure characterization of two functional polysaccharides from Polygonum multiflorum and its immunomodulatory.
    Qing Zhang, Yi Xu, Junjiang Lv, Mengxia Cheng, Ying Wu, Kun Cao, Xiaofeng Zhang, Xiuni Mou, Qi Fan (2018) - International journal of biological macromolecules
  19. THSG alleviates cerebral ischemia/reperfusion injury via the GluN2B-CaMKII-ERK1/2 pathway.
    Tonghe Liu, Jiayi Shi, Dahua Wu, Dandan Li, Yuhong Wang, Jian Liu, Pan Meng, Lijuan Hu, Chaojun Fu, Zhigang Mei, Jinwen Ge, Xiuli Zhang (2024) - Phytomedicine : international journal of phytotherapy and phytopharmacology
  20. Traditional Chinese Medicine Induced Liver Injury.
    Rolf Teschke (2014) - Journal of clinical and translational hepatology


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!